Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      Homepharmaceutical

      pharmaceutical

      Liquidia is Downgraded by Wedbush Following the Court’s Decision On the Principal Asset
      Investing News

      Liquidia is Downgraded by Wedbush Following the Court’s Decision On the Principal Asset

      September 1, 2022
      Japan Approves AstraZeneca’s Evusheld for the Treatment of COVID
      Investing News

      Japan Approves AstraZeneca’s Evusheld for the Treatment of COVID

      August 31, 2022
      Novavax Experiences a 52-Week Low as Pfizer and Moderna Receive FDA Approval for Improved Boosters
      Investing News

      Novavax Experiences a 52-Week Low as Pfizer and Moderna Receive FDA Approval for Improved Boosters

      August 31, 2022
      Ocean Biomedical and SPAC Aesther Healthcare Reach an Agreement for the Company to Go Public
      Investing News

      Ocean Biomedical and SPAC Aesther Healthcare Reach an Agreement for the Company to Go Public

      August 31, 2022
      Liquidia Weakness on the Judge’s Decision to Deny the Stay, Unchanged Thesis – Analysts
      Trading Tips

      Liquidia Weakness on the Judge’s Decision to Deny the Stay, Unchanged Thesis – Analysts

      August 30, 2022
      Amgen’s Year-to-Date Performance Exceeds Expectations; Now What?
      Investing News

      Amgen’s Year-to-Date Performance Exceeds Expectations; Now What?

      August 30, 2022
      What Caused Today’s Drop in Veru Stock?
      Investing News

      What Caused Today’s Drop in Veru Stock?

      August 30, 2022
      The FDA has given Sanofi’s hemophilia A drug BLA the Priority Review Status.
      Investing News

      The FDA has given Sanofi’s hemophilia A drug BLA the Priority Review Status.

      August 30, 2022
      Novartis’ Drug for Chronic Myeloid Leukemia Receives EC Approval
      Investing News

      Novartis’ Drug for Chronic Myeloid Leukemia Receives EC Approval

      August 30, 2022
      Trxade Prime Plus Program by TRxADE Health Introduces Next-Day Delivery Options
      Investing News

      Trxade Prime Plus Program by TRxADE Health Introduces Next-Day Delivery Options

      August 30, 2022
      « 1 … 12 13 14 15 16 … 19 »

       

      LATEST NEWS

      • Investing News Ulta Beauty’s Q3 2025 Earnings Highlight Growth
      • Investing News Beta Technologies Q3 IPO Insights
      • Investing News Salesforce Reports Robust Q3 2026 Earnings
      • Investing News Salesforce’s Stock Boost Amid Raised Guidance
      • Investing News Macy’s Q3 2025 Earnings Overview

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025